e-learning
resources
London 2016
Sunday, 04.09.2016
Clinical aspects of ILD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Novel lung function tests in patients with interstitial lung disease (ILD)
Frederik Trinkmann (Mannheim, Germany), Frederik Trinkmann, Katharina Roth, Daniel Saur, Martin Borggrefe, Joachim Saur, Julia D. Michels
Source:
International Congress 2016 – Clinical aspects of ILD
Session:
Clinical aspects of ILD
Session type:
Thematic Poster
Number:
803
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Frederik Trinkmann (Mannheim, Germany), Frederik Trinkmann, Katharina Roth, Daniel Saur, Martin Borggrefe, Joachim Saur, Julia D. Michels. Novel lung function tests in patients with interstitial lung disease (ILD). Eur Respir J 2016; 48: Suppl. 60, 803
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Pulmonary function tests as predictors of mortality in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Respiratory function in systemic sclerosis patients
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
The relation of six-minute walk test and lung function in interstitial lung disease
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Effect of pirfenidone on IPF progression
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
The prognostic factor in patients with myositis-associated interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Pulmonary function testing in children's interstitial lung disease
Source: Eur Respir Rev, 29 (157) 200019; 10.1183/16000617.0019-2020
Year: 2020
Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Total lung capacity size matching in fibrosis lung transplantation
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Changes in lung mechanics and gas exchange in patients with pulmonary sarcoidosis (PS)
Source: International Congress 2014 – Innovative technology and techniques in respiratory function
Year: 2014
Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015
What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD)
Source: International Congress 2014 – ILDs 5
Year: 2014
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept